FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between DOMS IPO and Mukka Proteins IPO.
DOMS IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mukka Proteins IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
DOMS IPO | Mukka Proteins IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Jm Financial Limited Bnp Paribas ICICI Securities Limited Iifl Securities Ltd |
Fedex Securities Pvt Ltd |
Registrar | Link Intime India Private Ltd | Cameo Corporate Services Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of DOMS IPO is up to ₹1,200.00 Cr whereas the issue size of the Mukka Proteins IPO is up to ₹224.00 Cr. The final issue price of DOMS IPO is ₹790.00 per share and of Mukka Proteins IPO is ₹28.00 per share.
DOMS IPO | Mukka Proteins IPO | |
---|---|---|
Face Value | ₹10 per share | ₹1 per share |
Issue Price (Lower) | ₹750.00 per share | ₹26.00 per share |
Issue Price (Upper) | ₹790.00 per share | ₹28.00 per share |
Issue Price (Final) | ₹790.00 per share | ₹28.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹75.00 per share | |
Market Lot Size | 18 shares | 535 shares |
Fresh Issue Size | 44,30,380 shares | 8,00,00,000 shares |
Fresh Issue Size (Amount) | up to ₹350.00 Cr | up to ₹224.00 Cr |
OFS Issue Size | 1,07,59,493 shares | |
OFS Issue Size (Amount) | up to ₹850.00 Cr | |
Issue Size Total | 1,51,89,873 shares | 8,00,00,000 shares |
Issue Size Total (Amount) | up to ₹1,200.00 Cr | up to ₹224.00 Cr |
DOMS IPO opens on Dec 13, 2023, while Mukka Proteins IPO opens on Feb 29, 2024. The closing date of DOMS IPO and Mukka Proteins IPO is Dec 15, 2023, and Mar 04, 2024, respectively.
DOMS IPO | Mukka Proteins IPO | |
---|---|---|
Anchor Bid Date | Dec 12, 2023 | Feb 28, 2024 |
Issue Open | Dec 13, 2023 | Feb 29, 2024 |
Issue Close | Dec 15, 2023 | Mar 04, 2024 |
Basis Of Allotment (Tentative) | Dec 18, 2023 | Mar 05, 2024 |
Initiation of Refunds (Tentative) | Dec 19, 2023 | Mar 06, 2024 |
Credit of Share (Tentative) | Dec 19, 2023 | Mar 06, 2024 |
Listing date (Tentative) | Dec 20, 2023 | Mar 07, 2024 |
Anchor Lockin End date 1 | Jan 17, 2024 | Apr 04, 2024 |
Anchor Lockin End date 2 | Mar 17, 2024 | Jun 03, 2024 |
DOMS IPO P/E ratio is 43.19, as compared to Mukka Proteins IPO P/E ratio of 12.96.
DOMS IPO | Mukka Proteins IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | DOMS Industries Limited Financial Information (Restated Consolidated)DOMS Industries Limited's revenue increased by 77.28% and profit after tax (PAT) rose by 500.18% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Mukka Proteins Limited Financial Information (Restated Consolidated)Mukka Proteins Limited's revenue increased by 52.52% and profit after tax (PAT) rose by 84.07% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 74.97% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 43.19 | 12.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹4793.77 Cr. | ₹840.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 33.54%% | 36.71%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 33.31%% | 17.62%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.28 | 1.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹18.29 | ₹2.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 28.39%% | 34.19%% |
In the DOMS IPO retail investors (RII) are offered 15,12,658 shares while in Mukka Proteins IPO retail investors are offered 15,12,658 shares. Qualified institutional buyers (QIB) are offered 45,37,975 shares in DOMS IPO and 1,60,00,435 shares in Mukka Proteins IPO.
DOMS IPO | Mukka Proteins IPO | |
---|---|---|
Anchor Investor Reserveration | 68,06,961 shares | 2,39,99,565 shares |
Market Maker Reserveration | ||
QIB | 45,37,975 shares | 1,60,00,435 shares |
NII | 22,68,987 shares | 1,20,00,000 shares |
RII | 15,12,658 shares | 2,80,00,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 83,19,620 shares | 5,60,00,435 shares |
DOMS IPO subscribed 99.34x in total, whereas Mukka Proteins IPO subscribed 136.99x.
DOMS IPO | Mukka Proteins IPO | |
---|---|---|
QIB (times) | 122.16x | 189.28x |
NII (times) | 70.06x | 250.39x |
Big NII (times) | 71.27x | 254.15x |
Small NII (times) | 67.65x | 242.86x |
RII (times) | 73.38x | 58.52x |
Employee (times) | ||
Other (times) | ||
Total (times) | 99.34x | 136.99x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|